No products in the cart.
The modified reverse valsalva for supraventricular tachycardia
Key Points: The Reverse Valsalva maneuver utilizes forced inspiration against an occluded airway to generate negative intrathoracic pressure and trigger...
Cardiology
Reports of high-impact cardiology studies by medical professionals
Television CPR scripts undercut bystander response in real emergencies
1. Televised CPR scenes still underrepresent hands-only compressions and realistic outcomes, shaping how viewers expect resuscitation to look. 2. Brief...
Oral semaglutide reshapes everyday obesity visits
1. Oral semaglutide adds a pill-based option for chronic obesity care without changing the core GLP-1 tradeoffs in efficacy and...
![2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]](data:image/svg+xml;nitro-empty-id=NzU1OjEzODI=-1;base64,PHN2ZyB2aWV3Qm94PSIwIDAgMSAxIiB3aWR0aD0iMSIgaGVpZ2h0PSIxIiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPjwvc3ZnPg==)
2 Minute Medicine: Pharma Roundup – New oral gonorrhea antibiotic Nuzolvence (zoliflodacin), late‑December cardiovascular and oncology drug approvals, first targeted complement inhibitor therapy for HSCT‑TMA (Yartemlea), and antibody‑drug conjugate (ADC) safety concerns with ifinatamab deruxtecan (I‑DXd) [January 2026]
Oral gonorrhea antibiotic Nuzolvence approved just weeks ago The Food and Drug Administration recently approved Nuzolvence (zoliflodacin) as a first‑in‑class...
The preoperative combination of evolocumab and rosuvastatin may not reduce major adverse cardiovascular events
1. Preoperative evolocumab combined with rosuvastatin did not significantly reduce six-month major adverse cardiovascular events but improved several clinically relevant...
Late ventricular fibrillation following myocardial infarction is associated with increased risk of 1-year mortality
1. Late ventricular fibrillation after acute myocardial infarction is associated with a markedly increased risk of 1-year mortality among patients...
The efficacy 3 months of dual antiplatelet therapy is similar to 12 months in patients with acute coronary syndrome
1. 3 months of dual antiplatelet therapy (DAPT) in patients treated with Firehawk stents was non-inferior to 12 months of...
Association between atrial fibrillation and both the in-hospital mortality and disease severity in acute pancreatitis: insights from a multicenter study
1. Among patients with acute pancreatitis (AP), a history of atrial fibrillation (AF) was associated with increased disease severity but...
The use of guideline-directed medical therapy for heart failure with reduced ejection fraction is suboptimal
1. Use of guideline-directed medical therapy (GDMT) in heart failure with reduced ejection fraction (HFrEF) and heart failure with mildly...
Reducing saturated fat decreases mortality in high-risk individuals
1. In this systematic review, reducing intake of saturated fatty acids (SFAs) showed possible benefit for mortality, non-fatal myocardial infarction...
